Huidong Shi

20PUBLICATIONS
61CO-AUTHORS
Haematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
Elevated dNTP Pool Levels Impair Homologous Recombination and Enhance Glioblastoma Sensitivity to Irradiation and Temozolomide.

|Oct 15, 2025
Genomic Analysis Defines Increased Circulating, Leukemia-Induced Macrophages That Promote Immune Suppression in Mouse Models of FGFR1-Driven Leukemogenesis.

Ting Zhang, Atsuko Matsunaga, Xiaocui Lu

|Aug 26, 2025
Slc7a5 promotes T cell anti-tumor immunity through sustaining cytotoxic T lymphocyte effector function.

Chunwan Lu, Liyan Liang, Yanmin Wu

|Aug 01, 2025
Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis.

Kendra Fick, Nicholas Kerns, Yang Zhao

|Mar 12, 2025
UFL1 promotes survival and function of virtual memory CD8 T cells.

Brinda Bhatt, Kunal Kumar, Huidong Shi

|Jan 06, 2025
Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice.

Caixia Xi, Junfeng Pang, Weinan Xue

Pageof 4

Frequent Collaborators

7 joint publications

Zhuoqi Liu

2 joint publications

Mercy Kehinde-Ige

2 joint publications

Ali S Arbab

2 joint publications

Xingguo Zhu